TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Binding affinity to recombinant full length EP300 (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by ...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Binding affinity to recombinant full length EP300 (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by ...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 2.5nMAssay Description:Binding affinity to recombinant full length EP300 (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by ...More data for this Ligand-Target Pair
Affinity DataIC50: 2.90nMAssay Description:Binding affinity to recombinant full length CBP (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by sc...More data for this Ligand-Target Pair
Affinity DataIC50: 3.20nMAssay Description:Binding affinity to recombinant full length CBP (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by sc...More data for this Ligand-Target Pair
Affinity DataIC50: 6.70nMAssay Description:Binding affinity to recombinant full length CBP (unknown origin) incubated for 30 mins followed by H3(1 to 21) addition and measured after 1 hr by sc...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 8.10nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 19nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 21nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 44nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 52nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 55nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 59nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 71nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 83nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 93nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetTranscription initiation factor TFIID subunit 1(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins...More data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 130nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 190nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 200nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 240nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 330nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 460nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 520nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 570nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Constellation Pharmaceuticals
Curated by ChEMBL
Constellation Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 770nMAssay Description:Binding affinity to recombinant N-terminal His-tagged EP300 HAT domain (unknown origin) (1287 to 1666 residues) expressed in Escherichia coli incubat...More data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 780nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetChromatin remodeling regulator CECR2(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged CECR2 expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET assayMore data for this Ligand-Target Pair
TargetTranscription initiation factor TFIID subunit 1(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged BRD9 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET as...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 1.60E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged BRD9 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET as...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 1.70E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged BRD9 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET as...More data for this Ligand-Target Pair
TargetTranscription initiation factor TFIID subunit 1(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 1.80E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins...More data for this Ligand-Target Pair
Affinity DataIC50: 1.90E+3nMAssay Description:Inhibition of CYP2C8 (unknown origin)More data for this Ligand-Target Pair
TargetTranscription initiation factor TFIID subunit 1(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 2.10E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins...More data for this Ligand-Target Pair
TargetTranscription initiation factor TFIID subunit 1(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins...More data for this Ligand-Target Pair
TargetBromodomain-containing protein 9(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged BRD9 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins by TR-FRET as...More data for this Ligand-Target Pair
TargetTranscription initiation factor TFIID subunit 1(Homo sapiens (Human))
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Genentech Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of recombinant human N-terminal His6-FLAG-tagged TAF1 bromodomain 2 (unknown origin) expressed in Rosetta2 (DE3) pLysS cells after 60 mins...More data for this Ligand-Target Pair